CHM vs ALA
CDH 17 licence announced July 2021 , IND granted 10 / 11 2023, trial opened May 2024
ALA's iNKT licence announced June 2021 ( back then SUD ), no IND or trial start
ALA's iNKT IL-12 ?????????????
IMU decided it is not worth to continue the co-op with ALA, so maybe ALA's iNKT is not to be expected to become the world's best liquid cancer CAR-T
ALA valued AUD 120m, CHM valued $20 including GBM and AML trials and FDA requests to advance this 2 to rego trials.
Who is right? The ALA investors or the CHM " deniers "?
GLTA
CHM vs ALACDH 17 licence announced July 2021 , IND granted 10 /...
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.7¢ |
Change
-0.001(5.56%) |
Mkt cap ! $14.66M | |||
| Open | High | Low | Value | Volume |
| 1.8¢ | 1.8¢ | 1.7¢ | $17.68K | 1.017M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 839780 | 1.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.8¢ | 397675 | 3 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
1.7¢ |
Change
-0.001 ( 5.56 %) |
||||
| Open | High | Low | Volume | ||
| 1.7¢ | 1.8¢ | 1.7¢ | 346666 | ||
| Last updated 15.52pm 14/06/2024 ? | |||||
| CHM (ASX) Chart |